[霍奇金淋巴瘤治疗当前标准]
1Medizinische Klinik und Poliklinik III, LMU Klinikum, LMU München, München, Germany.
Deutsche medizinische Wochenschrift (1946)
|May 23, 2024
概括
新的霍奇金淋巴瘤治疗方法,包括Brentuximab Vedotin和检查点抑制剂,改善结果并降低毒性. 这些进展为患有晚期或复发疾病的患者提供了新的希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 霍奇金淋巴瘤治疗已经显著发展.
- 优化治疗,同时最大限度地减少毒性是关键目标.
- 进步包括新的向疗法和免疫疗法.
研究的目的:
- 审查霍奇金淋巴瘤治疗的当前趋势.
- 总结一下最近的治疗进展.
- 讨论不同淋巴瘤亚型的不断发展的治疗策略.
主要方法:
- 最近临床试验和研究的文献综述.
- 对Brentuximab Vedotin和检查点抑制剂的数据分析.
- 对高级,复发性和耐火性霍奇金淋巴瘤的治疗模式的讨论.
主要成果:
- 布伦图西马布 (Brentuximab Vedotin) 在一线治疗中被纳入,对晚期霍奇金淋巴瘤显示出有前途.
- 检查点抑制剂在早期研究中显示出更高的疗效和更低的毒性.
- 检查点抑制可以重新定义复发/耐药霍奇金淋巴瘤的治疗方法,可能避免使用自身干细胞移植 (HD-ASCT) 进行高剂量化疗.
结论:
- 新型疗法正在改善霍奇金淋巴瘤治疗结果.
- 检查点抑制剂是一个重大进步,有可能替代或减少对特定患者的HD-ASCT的需要.
- 由于其独特的特征,结节性淋巴细胞占主导地位的霍奇金淋巴瘤需要不同的治疗策略.
相关概念视频
01:22Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K